ClariTrial | Search Clinical Trials

Phase 3Head and Neck Squamous Cell CarcinomaStage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8Stage II Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8

GabapentinPlaceboChemotheraphy+4 more

Alliance for Clinical Trials in Oncology228 participants187 sites · United StatesCompletes Aug 2029

Compare CT.gov Full analysis →

Recruiting

SBRT, Chemotherapy, and AK104 Neoadjuvant Therapy for Triple-negative Breast Cancer (TNBC)

Phase 2Breast Cancer

Cadonilimab (AK104)

Hubei Cancer Hospital51 participants1 site · ChinaCompletes Aug 2026

Compare CT.gov Full analysis →

Recruiting

Mebendazole as Adjuvant Treatment for Colon Cancer

Phase 3Colorectal Cancer

Folfox with avastinMebendazole

Sherief Abd-Elsalam40 participants1 site · EgyptCompletes Dec 2028

Compare CT.gov Full analysis →

1–15 of 6,246

Explore/cancer oncology

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

6,246 results for “cancer oncology” · Recruiting · Phase 3 · Phase 2

Page 1 of 417

Recruiting

Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer

Phase 2Differentiated Thyroid CancerPediatric CancerCancer

Larotrectinib monotherapy131I therapy

Children's Hospital of Philadelphia13 participants5 sites · United StatesCompletes Oct 2026

Compare CT.gov Full analysis →

Recruiting

DV in Combination With Pertuzumab With or Without Toripalimab Neoadjuvant Therapy With HER2-positive Breast Cancer

Phase 2Breast Cancer

Disitamab Vedotin InjectionPertuzumab InjectionToripalimab

RemeGen Co., Ltd.40 participants1 site · ChinaCompletes Jun 2026

Compare CT.gov Full analysis →

Recruiting

PD-1 Antibody Carilizumab Combined with Apatinib for Unresectable Stage III and IV DMMR Gastric Cancer

Phase 2Gastric Cancer

Carilizumab and Apatinib

Peking University Third Hospital20 participants1 site · ChinaCompletes Apr 2026

Compare CT.gov Full analysis →

Recruiting

Phase 1Phase 2Relapsed/Refractory Multiple Myeloma

SonrotoclaxDexamethasoneCarfilzomib+2 more

BeOne Medicines246 participants80 sites · United States, Australia, BrazilCompletes Nov 2026

Compare CT.gov Full analysis →

Recruiting

Investigating the Efficacy and Safety of Neoadjuvant Intravesical Instillation of Mitomycin C in Treating High-risk NMIBC Patients

Phase 3Non-Muscle-Invasive Bladder Cancer (NMIBC)

Mitomycin C (MMC)Normal Saline (Placebo)

Shaogang Wang180 participants3 sites · ChinaCompletes Jun 2027

Compare CT.gov Full analysis →

Recruiting

Wide Margin vs. Narrow Margin in Postneoadjuvant Lumpectomy

Phase 3Breast Cancer

BracketingNeoadjuvant therapyPost-treatment volume margin resection+1 more

Mansoura University370 participants1 site · EgyptCompletes Aug 2026

Compare CT.gov Full analysis →

Recruiting

A Study of ABT-301 Plus Tislelizumab With Bevacizumab in pMMR/Non-MSI-H Locally Advanced or mCRC

Phase 1Phase 2Colorectal Cancer (Diagnosis)Colorectal Cancer MetastaticColorectal Cancer (CRC)

ABT-301TislelizumabBevacizumab (Avastin)

Anbogen Therapeutics, Inc.66 participants15 sites · Australia, TaiwanCompletes Apr 2028

Compare CT.gov Full analysis →

Recruiting

Camrelizumab Plus Famitinib as Treatment in Patient With Advanced or Metastatic Pulmonary Sarcomatoid Carcinoma

Phase 2Sarcomatoid Carcinoma of Lung

CamrelizumabFamitinib

Qian Chu28 participants8 sites · ChinaCompletes Dec 2024

Compare CT.gov Full analysis →

Recruiting

Immunotherapy in Combination With Chemoradiotherapy in Unresectable Locally Advanced Esophageal Cancer

Phase 1Phase 2Esophageal Squamous Cell CarcinomaUnresectable Locally Advanced Esophageal Cancer

PD-1inhibitornab-paclitaxel + cisplatinRadiotherapy

Shanghai Chest Hospital50 participants1 site · ChinaCompletes Dec 2025

Compare CT.gov Full analysis →

Recruiting

RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial

Phase 2Adenocarcinoma of LungLung Cancer

Oral Restorative Microbiota Therapy (RMT) CapsulesDurvalumab 1500 mg IVCisplatin/pemetrexed or Carboplatin/pemetrexed+1 more

Masonic Cancer Center, University of Minnesota82 participants10 sites · United StatesCompletes Jan 2028

Compare CT.gov Full analysis →

Recruiting

Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma

Phase 2LeiomyosarcomaSarcoma

all-trans retinoic acidCemiplimabComputed Tomography+2 more

Gabriel Tinoco16 participants1 site · United StatesCompletes Dec 2027

Compare CT.gov Full analysis →

Recruiting

Prophylactic Preoperative HIPEC in Advanced Gastric Cancer at High Risk of Peritoneal Recurrence

Phase 3Gastric Cancer

FLOT + HIPEC + SurgeryFLOT + Surgery

Jagiellonian University600 participants1 site · PolandCompletes Jan 2026

Compare CT.gov Full analysis →

Recruiting

High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer

Phase 3Head and Neck Squamous Cell CarcinomaStage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8Stage II Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8

GabapentinPlaceboChemotheraphy+4 more

Alliance for Clinical Trials in Oncology228 participants187 sites · United StatesCompletes Aug 2029

Compare CT.gov Full analysis →

Recruiting

SBRT, Chemotherapy, and AK104 Neoadjuvant Therapy for Triple-negative Breast Cancer (TNBC)

Phase 2Breast Cancer

Cadonilimab (AK104)

Hubei Cancer Hospital51 participants1 site · ChinaCompletes Aug 2026

Compare CT.gov Full analysis →

Recruiting

Mebendazole as Adjuvant Treatment for Colon Cancer

Phase 3Colorectal Cancer

Folfox with avastinMebendazole

Sherief Abd-Elsalam40 participants1 site · EgyptCompletes Dec 2028

Compare CT.gov Full analysis →

1–15 of 6,246